Antibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN362892 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Eukaryotic Translation Initiation Factor 4E (EIF4E) (AA 207-211) antibody
- Antibody type
- Polyclonal
- Antigen
- Peptide sequence around AA 207-211 (S-G-S-T-T) derived from Human eIF4E. Antibodies were produced by immunizing rabbits with synthetic peptide and KLH conjugates.
- Description
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography usingepitope-specific immunogen.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Epitope
- AA 207-211
- Isotype
- IgG
- Vial size
- 100 μL
- Concentration
- 1 mg/mL
- Storage
- Store at -20°C for long term preservation (recommended). Store at 4°C for short term use.
Submitted references tRNASer(CGA) differentially regulates expression of wild-type and codon-modified papillomavirus L1 genes.
Tethered-function analysis reveals that elF4E can recruit ribosomes independent of its binding to the cap structure.
Clinical outcome in stage I to III breast carcinoma and eIF4E overexpression.
The C-terminal domain of eukaryotic protein synthesis initiation factor (eIF) 4G is sufficient to support cap-independent translation in the absence of eIF4E.
Nucleotide sequence of the gene encoding a 20 kDa protein associated with the cap binding protein eIF-4E from Saccharomyces cerevisiae.
Gu W, Li M, Zhao WM, Fang NX, Bu S, Frazer IH, Zhao KN
Nucleic acids research 2004;32(15):4448-61
Nucleic acids research 2004;32(15):4448-61
Tethered-function analysis reveals that elF4E can recruit ribosomes independent of its binding to the cap structure.
De Gregorio E, Baron J, Preiss T, Hentze MW
RNA (New York, N.Y.) 2001 Jan;7(1):106-13
RNA (New York, N.Y.) 2001 Jan;7(1):106-13
Clinical outcome in stage I to III breast carcinoma and eIF4E overexpression.
Li BD, McDonald JC, Nassar R, De Benedetti A
Annals of surgery 1998 May;227(5):756-6l; discussion 761-3
Annals of surgery 1998 May;227(5):756-6l; discussion 761-3
The C-terminal domain of eukaryotic protein synthesis initiation factor (eIF) 4G is sufficient to support cap-independent translation in the absence of eIF4E.
Ohlmann T, Rau M, Pain VM, Morley SJ
The EMBO journal 1996 Mar 15;15(6):1371-82
The EMBO journal 1996 Mar 15;15(6):1371-82
Nucleotide sequence of the gene encoding a 20 kDa protein associated with the cap binding protein eIF-4E from Saccharomyces cerevisiae.
Altmann M, Krieger M, Trachsel H
Nucleic acids research 1989 Sep 25;17(18):7520
Nucleic acids research 1989 Sep 25;17(18):7520
No comments: Submit comment
No validations: Submit validation data